Author:
Bagdas Deniz,AlSharari Shakir,Roni Monzurul A.,Campbell Vera C.,Muldoon Pretal P.,Carroll F. Ivy,Damaj M. Imad
Funder
National Institutes of Health
Reference52 articles.
1. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests;Andreasen;J. Psychopharmacol.,2009
2. Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?;Arias;Int. J. Biochem. Cell Biol.,2009
3. Bupropion: a review of its mechanism of antidepressant activity;Ascher;J. Clin. Psychiatry,1995
4. The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain;Bagdas;Biochem. Pharmacol.,2015
5. New approaches to antidepressant drug discovery: beyond monoamines;Berton;Nat. Rev. Neurosci.,2006